InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: None

Sunday, 08/18/2019 6:15:09 PM

Sunday, August 18, 2019 6:15:09 PM

Post# of 892
I found out that even Deciphera pharmaceuticals DCPH is also working in preclinical studies on an undisclosed kinase for cancer metabolism. It looks like TYME is paving the way, but the leader in this space right now. More biotechs probably to follow soon after. Good thing is that Tyme has plenty of patents protecting its type of kinase cancer metabolism.